1999
DOI: 10.1054/drup.1998.0059
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal resistance in non- albicans Candida species

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

2
35
2
2

Year Published

2002
2002
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(41 citation statements)
references
References 47 publications
2
35
2
2
Order By: Relevance
“…According to previous findings (7,15), AMB was fungicidal against all isolates tested, showing the greatest activity against C. lusitaniae isolates despite the fact that C. lusitaniae is known for rapid development of AMB resistance (4). Caspofungin displayed fungicidal activity against all isolates but C. lusitaniae 325, suggesting that its fungicidal activity is isolate and species specific.…”
supporting
confidence: 51%
See 1 more Smart Citation
“…According to previous findings (7,15), AMB was fungicidal against all isolates tested, showing the greatest activity against C. lusitaniae isolates despite the fact that C. lusitaniae is known for rapid development of AMB resistance (4). Caspofungin displayed fungicidal activity against all isolates but C. lusitaniae 325, suggesting that its fungicidal activity is isolate and species specific.…”
supporting
confidence: 51%
“…The culture was then incubated at 37°C with shaking. At predetermined time points (0,1,2,4,8,24, and 48 h), 100 l samples were removed and serially diluted in cold sterile distilled water, and 100 l was plated onto SDA for colony counting.PAFE. Growth control and test vials were prepared as for time-kill experiments.…”
mentioning
confidence: 99%
“…Candida albicans is the most common cause of candidemia, and in general has remained susceptible in vitro to both amphotericin B and fluconazole (11,12). As the use of fluconazole increases (1), however, it is important to monitor for any increase in azole resistance among bloodstream isolates of C. albicans or any increase in frequency of bloodstream infection due to Candida species other than C. albicans, which have a higher incidence of in vitro azole resistance (e.g., C. glabrata and Candida krusei) (3).…”
mentioning
confidence: 99%
“…Furthermore, development of resistance to conventional antifungal therapies has created concern regarding the future ability to treat infections caused by Candida spp. (9,23,38,63). Clearly, new strategies to prevent Candida infections are needed.…”
mentioning
confidence: 99%